Improving venous thromboembolism prophylaxis in hospitalized pediatric patients with inflammatory bowel disease

Objectives: Youth hospitalized with inflammatory bowel disease (IBD) are at risk for venous thromboembolism (VTE). Pharmacologic VTE prophylaxis with enoxaparin is routine in adults hospitalized with IBD, but standardized pediatric protocols are rare. Using quality improvement methods, we aimed to increase the rate of pharmacologic VTE prophylaxis amongst select hospitalized patients with IBD by reaching 90% algorithm adherence by June 2023 and sustaining. Methods: Current evidence, external institutional algorithms, and multidisciplinary collaboration (hematology, pharmacy, surgery) were used to create an algorithm for providing pharmacologic VTE prophylaxis with enoxaparin. The algorithm was implemented in February 2023 for all patients admitted with active IBD to a large, tertiary care children's hospital. Rates of algorithm adherence and rates of enoxaparin receipt during the project period were compared to baseline rates. Patient and provider education, electronic data tracking, and regular data auditing and review with providers were used to improve algorithm adherence. Reasons for non-adherence to the algorithm and rates of VTE, bleeding complications, and medication side effects during hospitalization were tracked. Results: < 0.001). Following algorithm introduction, there were no VTEs or reported complications from enoxaparin during hospitalization. Conclusions: The introduction of a standardized algorithm was associated with significantly increased rates of pharmacologic VTE prophylaxis amongst children hospitalized with IBD with no recorded adverse in-hospital events.

Authors

Institutions

Publication Details

Journal
JPGN Reports
Published
2026-11-17
DOI
https://doi.org/10.1002/jpr3.70264
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Improving venous thromboembolism prophylaxis in hospitalized pediatric patients with inflammatory bowel disease

Jennifer L. Dotson, Laura G. Hamant, Vilmarie Rodriguez, Hilary K. Michel et al.
1 links
JPGN Reports
Venous Thromboembolism Diagnosis and Management
article

Improving venous thromboembolism prophylaxis in hospitalized pediatric patients with inflammatory bowel disease

Jennifer L. Dotson, Laura G. Hamant, Vilmarie Rodriguez, Hilary K. Michel, Ross M. Maltz, Brendan Boyle
article en

Abstract

Objectives: Youth hospitalized with inflammatory bowel disease (IBD) are at risk for venous thromboembolism (VTE). Pharmacologic VTE prophylaxis with enoxaparin is routine in adults hospitalized with IBD, but standardized pediatric protocols are rare. Using quality improvement methods, we aimed to increase the rate of pharmacologic VTE prophylaxis amongst select hospitalized patients with IBD by reaching 90% algorithm adherence by June 2023 and sustaining. Methods: Current evidence, external institutional algorithms, and multidisciplinary collaboration (hematology, pharmacy, surgery) were used to create an algorithm for providing pharmacologic VTE prophylaxis with enoxaparin. The algorithm was implemented in February 2023 for all patients admitted with active IBD to a large, tertiary care children's hospital. Rates of algorithm adherence and rates of enoxaparin receipt during the project period were compared to baseline rates. Patient and provider education, electronic data tracking, and regular data auditing and review with providers were used to improve algorithm adherence. Reasons for non-adherence to the algorithm and rates of VTE, bleeding complications, and medication side effects during hospitalization were tracked. Results: < 0.001). Following algorithm introduction, there were no VTEs or reported complications from enoxaparin during hospitalization. Conclusions: The introduction of a standardized algorithm was associated with significantly increased rates of pharmacologic VTE prophylaxis amongst children hospitalized with IBD with no recorded adverse in-hospital events.

JPGN Reports
Arkansas Children's Hospital (US), Nationwide Children's Hospital (US), The Ohio State University (US), University of Arkansas for Medical Sciences (US)
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon